Skip to main content

Articles

Original Research
Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment
Stakeholder Perspective
Closing Gaps in Health Plan Performance with Stakeholder Collaboration
Read More
Original Research, Practice Management
Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease
Stakeholder Perspective
A Teachable Moment in Health Benefits Design
Read More
Practice Management
Transforming the Drug Cost Paradigm from Payment for Medications to Payment for Value
Read More
Practice Management
Healthcare Utilization and Costs of Knee or Hip Replacements versus Pain-Relief Injections
Stakeholder Perspective
Knee and Hip Pain: Rewarding Optimal Long-Term Management
Read More
FDA Approvals
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder
Read More
FDA Approvals
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer
Read More
Introduction
The Continuing Clinical and Economic Burden of Cardiometabolic Health
Read More
Perspectives
Compensation for Managing Population Health
Read More
Original Research
Longitudinal Commercial Claims–Based Cost Analysis of Diabetic Retinopathy Screening Patterns
Stakeholder Perspective
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
Read More
Practice Management
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
Stakeholder Perspective
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Read More
Page 126 of 244
Results 1251 - 1260 of 2436